Immune therapeutic potential of stem cells from human supernumerary teeth

Y. Makino, H. Yamaza, Kentaro Akiyama, L. Ma, Y. Hoshino, K. Nonaka, Y. Terada, T. Kukita, S. Shi, T. Yamaza

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Discoveries of immunomodulatory functions in mesenchymal stem cells (MSCs) have suggested that they might have therapeutic utility in treating immune diseases. Recently, a novel MSC population was identified from dental pulp of human supernumerary teeth, and its multipotency characterized. Herein, we first examined the in vitro and in vivo immunomodulatory functions of human supernumerary tooth-derived stem cells (SNTSCs). SNTSCs suppressed not only the viability of T-cells, but also the differentiation of interleukin 17 (IL-17)-secreting helper T (Th17) -cells in in vitro co-culture experiments. In addition, systemic SNTSC transplantation ameliorated the shortened lifespan and elevated serum autoantibodies and nephritis-like renal dysfunction in systemic lupus erythematosus (SLE) model MRL/lpr mice. SNTSC transplantation also suppressed in vivo increased levels of peripheral Th17 cells and IL-17, as well as ex vivo differentiation of Th17 cells in MRL/lpr mice. Adoptive transfer experiments demonstrated that SNTSC-transplanted MRL/lpr mouse-derived T-cell-adopted immunocompromised mice showed a longer lifespan in comparison with non-transplanted MRL/lpr mouse-derived T-cell-adopted immunocompromised mice, indicating that SNTSC transplantation suppresses the hyper-immune condition of MRL/lpr mice through suppressing T-cells. Analysis of these data suggests that SNTSCs are a promising MSC source for cell-based therapy for immune diseases such as SLE.

Original languageEnglish
Pages (from-to)609-615
Number of pages7
JournalJournal of Dental Research
Volume92
Issue number7
DOIs
Publication statusPublished - Jul 2013
Externally publishedYes

Fingerprint

Supernumerary Tooth
Inbred MRL lpr Mouse
Stem Cells
Th17 Cells
Stem Cell Transplantation
Mesenchymal Stromal Cells
T-Lymphocytes
Interleukin-17
Immune System Diseases
Therapeutics
Systemic Lupus Erythematosus
Dental Pulp
Adoptive Transfer
Nephritis
Cell- and Tissue-Based Therapy
Helper-Inducer T-Lymphocytes
Coculture Techniques
Autoantibodies
Cell Differentiation
Kidney

Keywords

  • dental pulp
  • immunotherapy
  • mesenchymal stem cells
  • supernumerary teeth
  • systemic lupus erythematosus
  • T-cells

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

Immune therapeutic potential of stem cells from human supernumerary teeth. / Makino, Y.; Yamaza, H.; Akiyama, Kentaro; Ma, L.; Hoshino, Y.; Nonaka, K.; Terada, Y.; Kukita, T.; Shi, S.; Yamaza, T.

In: Journal of Dental Research, Vol. 92, No. 7, 07.2013, p. 609-615.

Research output: Contribution to journalArticle

Makino, Y, Yamaza, H, Akiyama, K, Ma, L, Hoshino, Y, Nonaka, K, Terada, Y, Kukita, T, Shi, S & Yamaza, T 2013, 'Immune therapeutic potential of stem cells from human supernumerary teeth', Journal of Dental Research, vol. 92, no. 7, pp. 609-615. https://doi.org/10.1177/0022034513490732
Makino, Y. ; Yamaza, H. ; Akiyama, Kentaro ; Ma, L. ; Hoshino, Y. ; Nonaka, K. ; Terada, Y. ; Kukita, T. ; Shi, S. ; Yamaza, T. / Immune therapeutic potential of stem cells from human supernumerary teeth. In: Journal of Dental Research. 2013 ; Vol. 92, No. 7. pp. 609-615.
@article{8e068ded5b094b52b574994014a9032a,
title = "Immune therapeutic potential of stem cells from human supernumerary teeth",
abstract = "Discoveries of immunomodulatory functions in mesenchymal stem cells (MSCs) have suggested that they might have therapeutic utility in treating immune diseases. Recently, a novel MSC population was identified from dental pulp of human supernumerary teeth, and its multipotency characterized. Herein, we first examined the in vitro and in vivo immunomodulatory functions of human supernumerary tooth-derived stem cells (SNTSCs). SNTSCs suppressed not only the viability of T-cells, but also the differentiation of interleukin 17 (IL-17)-secreting helper T (Th17) -cells in in vitro co-culture experiments. In addition, systemic SNTSC transplantation ameliorated the shortened lifespan and elevated serum autoantibodies and nephritis-like renal dysfunction in systemic lupus erythematosus (SLE) model MRL/lpr mice. SNTSC transplantation also suppressed in vivo increased levels of peripheral Th17 cells and IL-17, as well as ex vivo differentiation of Th17 cells in MRL/lpr mice. Adoptive transfer experiments demonstrated that SNTSC-transplanted MRL/lpr mouse-derived T-cell-adopted immunocompromised mice showed a longer lifespan in comparison with non-transplanted MRL/lpr mouse-derived T-cell-adopted immunocompromised mice, indicating that SNTSC transplantation suppresses the hyper-immune condition of MRL/lpr mice through suppressing T-cells. Analysis of these data suggests that SNTSCs are a promising MSC source for cell-based therapy for immune diseases such as SLE.",
keywords = "dental pulp, immunotherapy, mesenchymal stem cells, supernumerary teeth, systemic lupus erythematosus, T-cells",
author = "Y. Makino and H. Yamaza and Kentaro Akiyama and L. Ma and Y. Hoshino and K. Nonaka and Y. Terada and T. Kukita and S. Shi and T. Yamaza",
year = "2013",
month = "7",
doi = "10.1177/0022034513490732",
language = "English",
volume = "92",
pages = "609--615",
journal = "Journal of Dental Research",
issn = "0022-0345",
publisher = "SAGE Publications Inc.",
number = "7",

}

TY - JOUR

T1 - Immune therapeutic potential of stem cells from human supernumerary teeth

AU - Makino, Y.

AU - Yamaza, H.

AU - Akiyama, Kentaro

AU - Ma, L.

AU - Hoshino, Y.

AU - Nonaka, K.

AU - Terada, Y.

AU - Kukita, T.

AU - Shi, S.

AU - Yamaza, T.

PY - 2013/7

Y1 - 2013/7

N2 - Discoveries of immunomodulatory functions in mesenchymal stem cells (MSCs) have suggested that they might have therapeutic utility in treating immune diseases. Recently, a novel MSC population was identified from dental pulp of human supernumerary teeth, and its multipotency characterized. Herein, we first examined the in vitro and in vivo immunomodulatory functions of human supernumerary tooth-derived stem cells (SNTSCs). SNTSCs suppressed not only the viability of T-cells, but also the differentiation of interleukin 17 (IL-17)-secreting helper T (Th17) -cells in in vitro co-culture experiments. In addition, systemic SNTSC transplantation ameliorated the shortened lifespan and elevated serum autoantibodies and nephritis-like renal dysfunction in systemic lupus erythematosus (SLE) model MRL/lpr mice. SNTSC transplantation also suppressed in vivo increased levels of peripheral Th17 cells and IL-17, as well as ex vivo differentiation of Th17 cells in MRL/lpr mice. Adoptive transfer experiments demonstrated that SNTSC-transplanted MRL/lpr mouse-derived T-cell-adopted immunocompromised mice showed a longer lifespan in comparison with non-transplanted MRL/lpr mouse-derived T-cell-adopted immunocompromised mice, indicating that SNTSC transplantation suppresses the hyper-immune condition of MRL/lpr mice through suppressing T-cells. Analysis of these data suggests that SNTSCs are a promising MSC source for cell-based therapy for immune diseases such as SLE.

AB - Discoveries of immunomodulatory functions in mesenchymal stem cells (MSCs) have suggested that they might have therapeutic utility in treating immune diseases. Recently, a novel MSC population was identified from dental pulp of human supernumerary teeth, and its multipotency characterized. Herein, we first examined the in vitro and in vivo immunomodulatory functions of human supernumerary tooth-derived stem cells (SNTSCs). SNTSCs suppressed not only the viability of T-cells, but also the differentiation of interleukin 17 (IL-17)-secreting helper T (Th17) -cells in in vitro co-culture experiments. In addition, systemic SNTSC transplantation ameliorated the shortened lifespan and elevated serum autoantibodies and nephritis-like renal dysfunction in systemic lupus erythematosus (SLE) model MRL/lpr mice. SNTSC transplantation also suppressed in vivo increased levels of peripheral Th17 cells and IL-17, as well as ex vivo differentiation of Th17 cells in MRL/lpr mice. Adoptive transfer experiments demonstrated that SNTSC-transplanted MRL/lpr mouse-derived T-cell-adopted immunocompromised mice showed a longer lifespan in comparison with non-transplanted MRL/lpr mouse-derived T-cell-adopted immunocompromised mice, indicating that SNTSC transplantation suppresses the hyper-immune condition of MRL/lpr mice through suppressing T-cells. Analysis of these data suggests that SNTSCs are a promising MSC source for cell-based therapy for immune diseases such as SLE.

KW - dental pulp

KW - immunotherapy

KW - mesenchymal stem cells

KW - supernumerary teeth

KW - systemic lupus erythematosus

KW - T-cells

UR - http://www.scopus.com/inward/record.url?scp=84879150884&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879150884&partnerID=8YFLogxK

U2 - 10.1177/0022034513490732

DO - 10.1177/0022034513490732

M3 - Article

VL - 92

SP - 609

EP - 615

JO - Journal of Dental Research

JF - Journal of Dental Research

SN - 0022-0345

IS - 7

ER -